NextSense is building a neurotech platform that is initially focused on sleep enhancement technologies for the growing consumer sleep tech market, The Company is addressing the need for accessible, noninvasive, and efficacious sleep monitoring and sleep enhancement solutions.
Read the full story here.
The Company is a leader in the growing field of microbiome-based medicine, which is exploring how the trillions of microorganisms in our bodies influence our health and how they might be leveraged for better medical treatments.
Read the full story here.
In this 90 day reprieve on the higher tariffs for all but China, we, like most investors, are working with our existing companies and prospective investments to understand the potential impact of tariffs…
Read the full story here.
Actress, Joylux investor and strategic brand partner - Halle Berry - was featured on Oprah's special, alongside a panel of medical experts and leading voices to discuss the traditionally taboo topic of menopause…
Read the full story here.
2025 is already off to a great start, with groundbreaking healthcare advancements lighting up the industry…
Read the full story here.
Paterna Bioscience is a biotech company focused on the rapidly growing $20B+ infertility market…
Read the full story here.
Many of us are caregivers for our elderly parents or sick family members. If you've been a caregiver, you know the time and energy that goes into this labor of love…
Read the full story here.
The care economy is one of the largest segments of care in the world. A recent report by Columbia University Mailman School of Public Health, and sponsored by Otsuka says…
Read the full story here.
Our portfolio company teams have skillfully navigated the ever-shifting market landscape, fostering both growth and resilience…
Read the full story here.
Gabbi is an emerging leader in breast cancer screening and detection markets, focusing on early risk assessment and care…
Read the full story here.
We have some initial predictions on how the new administration will impact the venture capital and healthcare industries…
Read the full story here.
HLTH2024, one of the largest and most important healthcare conferences of the year, took place October 20 - 23 in Las Vegas, NV….
Read the full story here.
Capita3 Fund II & IIA portfolio company Claros Technologies announced yesterday the completion of the first successful pilot…
Read the full story here.
We know that women-founded companies demonstrate 35% better returns and 2x more revenue per dollar invested than their male counterparts, yet these entrepreneurs continue to face significant challenges when raising capital…
Read the full story here.
For us, the top 2024 event was the Recast Capital Summit in Sonoma. This was a venture capital emerging manager event set in California’s wine country…
Read the full story here.
In the realm of asset allocation, what role do investments in venture capital funds and emerging managers play? Capita3 had the opportunity to speak with key opinion leaders in institutional asset allocation…
Read the full story here.
We are cautiously optimistic the liquidity market is rebounding. This optimism is balance by the election cycle, which will likely create market volatility but overall we are bullish…
Read the full story here.
The groundbreaking impact of AI and machine learning in advancing healthcare diagnostics is truly remarkable…
Read the full story here.
Claros Technologies, Inc. (ClarosTech™), the leader in PFAS analytical and destruction technologies, announced today that it has raised $22M…
Read the full story here.
Capita3 Funds I, II, and IIA are aimed at the intersection of digital health and deep tech, where hugely underserved sectors relative to their potential are opening up…
Read the full story here.
